[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Harvard Bioscience (HBIO)

Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,098
  • Shares Outstanding, K 4,510
  • Annual Sales, $ 86,550 K
  • Annual Income, $ -56,700 K
  • EBIT $ 3 M
  • EBITDA $ 59 M
  • 60-Month Beta 1.57
  • Price/Sales 0.35
  • Price/Cash Flow 0.58
  • Price/Book 2.21

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 106.42%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,147.49% on 03/12/26
  • IV Low 0.00% on 05/08/26
  • Expected Move (DTE 0) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 30
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 1,345
  • Open Int (30-Day) 1,702
  • Expected Range 4.85 to 4.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.20
  • Growth Rate Est. (year over year) +499,600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.34 +63.59%
on 04/13/26
7.50 -5.33%
on 05/06/26
+2.79 (+64.73%)
since 04/10/26
3-Month
4.00 +77.50%
on 03/12/26
7.50 -5.33%
on 05/06/26
+1.66 (+30.56%)
since 02/11/26
52-Week
2.81 +152.40%
on 05/28/25
9.50 -25.26%
on 05/29/25
+3.95 (+125.40%)
since 05/09/25

Most Recent Stories

More News
Harvard Bioscience to Participate in Upcoming Investor Conferences

HOLLISTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced Chief Executive Officer, John Duke and Chief Financial Officer, Mark Frost’s participation...

HBIO : 7.15 (+3.70%)
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

HOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2026, before the market opens on May...

HBIO : 7.15 (+3.70%)
Harvard Bioscience: Q4 Earnings Snapshot

Harvard Bioscience: Q4 Earnings Snapshot

HBIO : 7.15 (+3.70%)
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Fourth Quarter 2025 Revenues of $23.7M and Gross Margin of 59.7% Full Year 2025 Revenues of $86.6M and Gross Margin of 57.7% Interim CFO Mark Frost Appointed CFO on Permanent Basis Introduces...

HBIO : 7.15 (+3.70%)
Harvard Bioscience Announces Reverse Stock Split

Harvard Bioscience’s common stock is expected to begin trading on a post-split adjusted basis on March 16, 2026 HOLLISTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:...

HBIO : 7.15 (+3.70%)
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum

HOLLISTON, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that John Duke, President and Chief Executive Officer, and Mark Frost, Interim Chief Financial...

HBIO : 7.15 (+3.70%)
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

HOLLISTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2025, before the market opens on March...

HBIO : 7.15 (+3.70%)
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and...

HBIO : 7.15 (+3.70%)
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant  Initiative expected to deliver approximately $3 million in cost savings in 2027...

HBIO : 7.15 (+3.70%)
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flexibility BroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board...

HBIO : 7.15 (+3.70%)

Business Summary

HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

See More

Key Turning Points

3rd Resistance Point 7.43
2nd Resistance Point 7.28
1st Resistance Point 7.09
Last Price 7.15
1st Support Level 6.75
2nd Support Level 6.60
3rd Support Level 6.40

See More

52-Week High 9.50
Last Price 7.15
Fibonacci 61.8% 6.95
Fibonacci 50% 6.16
Fibonacci 38.2% 5.37
52-Week Low 2.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.